BRD-K49327517-001-01-9 (Substance)

Compound:

3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Synonyms:BRD-K49327517-001-01-9

Id:177749801

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K49327517-001-01-9's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 LJP006 SKBR3 24H L19 THZ-2-98-01 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 A549 24H L24 THZ-2-98-01 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 MCF10A 3H L23 THZ-2-98-01 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 HEPG2 24H L20 THZ-2-98-01 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 PC3 24H L20 THZ-2-98-01 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP006 A549 24H L21 THZ-2-98-01 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 LJP001 MCF10A 6H O02 THZ-2-98-01 2.22uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC LJP006 HME1 24H L23 THZ-2-98-01 0.12um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC LJP006 SKBR3 24H L20 THZ-2-98-01 3.33um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 LJP001 MDAMB231 6H P02 THZ-2-98-01 0.08uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 SKBR3 24H L19 THZ-2-98-01 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 A549 24H L24 THZ-2-98-01 0.04uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 MCF10A 3H L23 THZ-2-98-01 0.12uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 HEPG2 24H L20 THZ-2-98-01 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 PC3 24H L20 THZ-2-98-01 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP006 A549 24H L21 THZ-2-98-01 1.11uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 LJP001 MCF10A 6H O02 THZ-2-98-01 2.22uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC LJP006 HME1 24H L23 THZ-2-98-01 0.12um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC LJP006 SKBR3 24H L20 THZ-2-98-01 3.33um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC 2021 LJP001 MDAMB231 6H P02 THZ-2-98-01 0.08uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.